PCV-2 experiment treatment groups | Body Weight (Kg) | ADWG (Kg) | ||||
SD-5 | SD62 | SD83 | ADWG SD5-SD62 | ADWG SD62-SD83 | ADWG SD5-SD83 | |
NV-NC | 3.80 ± 0.85 | 41.95 ± 8.75 | 63.43 ± 9.25 | 0.57 ± 0.12 | 1.02 ± 0.10 | 0.68 ± 0.10 |
NV-C PCV-2 | 3.81 ± 0.68 | 38.80 ± 6.31 | 60.61 ± 7.56 | 0.52 ± 0.09 | 1.04 ± 0.13 | 0.65 ± 0.08 |
VS-C PCV-2 | 3.69 ± 0,49 | 37.25 ± 6.16 | 56.96 ± 8,15 | 0.50 ± 0.09 | 0.94 ± 0.19 | 0.61 ± 0.09 |
VC-C PCV-2 | 3.65 ± 0.52 | 37.31 ± 4.27 | 57.61 ± 5.52 | 0.50 ± 0.06 | 0.97 ± 0.11 | 0.61 ± 0.06 |
Mhyo experiment treatment groups | Body Weight (Kg) | ADWG (Kg) | ||||
SD-5 | SD62 | SD91 | ADWG SD5-SD62 | ADWG SD62-SD91 | ADWG SD5-SD91 | |
NV-NC | 3.80 ± 0.85 | 41.95 ± 8.75 | 70,22 ± 4.66 | 0.57 ± 0.12 | 1.05 ± 0.11 | 0.69 ± 0.05 |
NV-C Mhyo | 3.77 ± 0.65 | 39.51 ± 4.96 | 66.09 ± 10.67 | 0.53 ± 0.07 | 0.92 ± 0.25 | 0.65 ± 0.11 |
VS-C Mhyo | 3.77 ± 0.63 | 36.97 ± 4.30 | 64.48 ± 5.93 | 0.50 ± 0.06 | 0.95 ± 0.11 | 0.63 ± 0.06 |
VC-C Mhyo | 3.81 ± 0.69 | 41.06 ± 4.86 | 70.33 ± 5.85 | 0.55 ± 0.06 | 1.01 ± 0.07 | 0.69 ± 0.06 |